The Cabinet Secretariat has directed the Union Health Ministry to examine safety and quality concerns involving coronary stents manufactured in India after reports that three drug-eluting stent models were withdrawn in Sri Lanka. The development follows a representation by Rajya Sabha MP and medical doctor